Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | twik family of potassium channels-related | 0.0637 | 0.5281 | 0.5939 |
Loa Loa (eye worm) | hypothetical protein | 0.0599 | 0.462 | 0.8182 |
Echinococcus multilocularis | Two pore potassium channel protein sup 9 | 0.0637 | 0.5281 | 1 |
Trypanosoma cruzi | inositol 1,4,5-trisphosphate receptor, putative | 0.0503 | 0.2962 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0485 | 0.2657 | 0.2783 |
Trypanosoma brucei | inositol 1,4,5-trisphosphate receptor | 0.0503 | 0.2962 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0581 | 0.4302 | 0.7308 |
Leishmania major | hypothetical protein, conserved | 0.0342 | 0.0189 | 0.5 |
Schistosoma mansoni | ryanodine receptor related | 0.0596 | 0.457 | 0.4331 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.0742 | 0.7075 | 1 |
Brugia malayi | Twik (KCNK-like) family of potassium channels, alpha subunit 38. C. elegans sup-9 ortholog | 0.0637 | 0.5281 | 0.1309 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0426 | 0.1645 | 0.3115 |
Echinococcus granulosus | ryanodine receptor 44f | 0.0426 | 0.1645 | 0.3115 |
Loa Loa (eye worm) | hypothetical protein | 0.0637 | 0.5281 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.057 | 0.4113 | 0.6788 |
Loa Loa (eye worm) | hypothetical protein | 0.0637 | 0.5281 | 1 |
Echinococcus granulosus | Two pore potassium channel protein sup 9 | 0.0637 | 0.5281 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | uM | In vitro concentration of the compound required to inhibit classical pathway complement induced hemolysis in human; NA= not active | ChEMBL. | 11425522 |
IC50 (functional) | 0 uM | In vitro concentration of the compound required to inhibit classical pathway complement induced hemolysis in human; NA= not active | ChEMBL. | 11425522 |
IC50 (functional) | 0 uM | Cytotoxicity of the compound against human malignant melanoma cell line SK-MEL; NA= not active | ChEMBL. | 11425522 |
TI (functional) | 0 | In vitro therapeutic index (IC50 cytotoxicity/ IC50 complement inhibition) of the compound was determined; ND=no data | ChEMBL. | 11425522 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.